Altanib NOVA 400 mg Tablet
28,55$
22,27$
Altanib NOVA 400 mg Tablet is an innovative anticancer treatment designed to target specific types of leukemia and various blood cell disorders, offering hope for patients facing these challenging conditions. This medication is particularly effective against gastrointestinal stromal tumors (GIST), which develop in the digestive tract's walls and can metastasize to other body areas. Additionally, Altanib NOVA is utilized for managing protuberant tumors that are inoperable, have spread, or have recurred post-surgery, providing a crucial therapeutic option for those affected. By inhibiting the growth of cancerous cells, Altanib NOVA helps to slow disease progression and improve patient outcomes. It’s essential for patients to discuss potential side effects and contraindications with their healthcare provider to ensure a safe treatment journey. Regular monitoring is recommended to evaluate the effectiveness and adjust dosages as needed. With its targeted approach, Altanib NOVA 400 mg Tablet represents a significant advancement in cancer care, reinforcing the importance of personalized treatment strategies.
Quantité
Active Pharmaceutical Ingredient
Uses
• Altanib nova 400 mg tablet is primarily utilized in the management of Chronic Myelogenous Leukemia (CML). This type of cancer affects the blood-forming cells in the bone marrow, leading to an overproduction of abnormal white blood cells. The medication works by targeting specific pathways involved in the growth of these cancerous cells. Patients diagnosed with CML may benefit significantly from this treatment, as it helps control the progression of the disease.
• In addition to its role in treating CML, Altanib nova 400 mg tablet may be prescribed in specific cases where patients exhibit resistance to other therapies. This can occur when traditional treatments are ineffective or when the cancer has advanced. By providing an alternative therapeutic option, Altanib nova 400 mg tablet can help improve patient outcomes. Regular monitoring is essential to assess the effectiveness of the treatment.
• Altanib nova 400 mg tablet is often part of a comprehensive treatment plan for patients with CML. It may be used in conjunction with other medications or therapies to enhance overall efficacy. The aim is to achieve better disease control and improve the quality of life for those affected. Healthcare providers typically evaluate the patient's response to the medication to ensure optimal management of the condition.
• Healthcare professionals may recommend Altanib nova 400 mg tablet for patients who are newly diagnosed with Chronic Myelogenous Leukemia. Initiating treatment early can be crucial in slowing disease progression and minimizing complications. The tablet is designed to target the underlying mechanisms of CML, allowing patients to maintain a more stable health status. Close follow-up and supportive care are important aspects of the treatment regimen.
Benefits
Altanib NOVA 400 mg Tablet helps to reduce the size of cancerous tumors and slow the growth of cancer cells.
Altanib NOVA Tablet can be used as part of a treatment plan to help increase the chances of remission or cure in patients with certain types of cancer.
Altanib NOVA 400 mg Tablet can help to reduce the number and severity of cancer-related symptoms, such as fatigue, pain, and nausea.
Altanib NOVA 400 mg Tablet can be taken orally, which makes it easier for patients to take the medication, and Altanib NOVA 400 mg Tablet has relatively few side effects compared to other cancer treatments, such as chemotherapy.
Side Effects
Adverse reactions may occur with the use of Altanib NOVA 400 mg Tablet. Should you notice any of these side effects, it is advisable to consult your doctor or healthcare professional without delay. Your doctor can offer guidance on managing or alleviating these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Joint Pain
• Bone pain
• Muscle Cramps
• Sweating
• Watery Eyes
• Pink Eyes
• Flushing
• Itching
• Hair loss
Common Side Effects
• Shortness Of Breath
• Irregular Heartbeats
• Chest Pain
• Blistered skin
• Blood in Stool
• Severe Abdominal Pain and Bloating
• Blood in sputum
• High Fever
• Intestinal Bleeding
• Hepatic problems
• Diarrhea
• Dry mouth
• Loss of appetite
• Weight loss
• Headache
• Nail Color Changes
• Chills
• Sore throat
• Frequent Urination
• Tiredness
How To Use
Altanib NOVA 400 mg can be taken with food or as directed by your doctor. It is best to take the same time daily to improve the clinical condition. If you miss a dose of Altanib NOVA 400 mg Tablet take your next dose at your regularly scheduled time. The dose and duration of remedy will depend upon your condition. Do not stop taking this medicine without consulting your doctor.
Safety Advice
• Alcohol: The consumption of alcohol is generally not recommended when using Altanib NOVA Tablet due to the increased risk of liver damage. It is best to either avoid alcohol altogether or limit its consumption while undergoing any medication.
• Kidney: Altanib NOVA 400 mg Tablet should be used with mild kidney disease patients (CrCl 40 to <60 mL/min): Doses >600 mg/day are not recommended and moderate kidney patients (CrCl 20 to <40 mL/min). Decrease dose by 50%; may increase future doses if tolerated. Altanib NOVA 400 mg Tablet used in caution patients with severe kidney disease take 100-mg/day dose was tolerated.
• Breastfeeding: The excretion of Altanib NOVA Tablet in human milk is currently unknown. Considering that various drugs, including other anthracyclines, are excreted in human milk and the possibility of severe adverse reactions in nursing infants from Altanib NOVA 400 mg Tablet, it is recommended that lactating women refrain from breastfeeding while undergoing treatment with Altanib NOVA Tablet and for a minimum of 7 days after the final dose.
• Liver: Patients with liver disease should exercise caution when using Altanib NOVA 400 mg Tablet. It is crucial for individuals with liver disease to closely observe their liver function while using Altanib NOVA 400 mg Tablet and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Altanib NOVA 400 mg Tablet may be necessary for patients with liver disease.
• Pregnancy: The use of Altanib NOVA 400 mg Tablet during pregnancy may not be safe, as indicated by animal studies that suggest potential harm to the developing foetus. However, if you are currently pregnant or planning to become pregnant, it is crucial to consult your doctor about the potential risks and benefits of using Altanib NOVA 400 mg Tablet during pregnancy. Your doctor will be able to assist you in making the most appropriate decision for the health and well-being of both you and your baby.
• Driving: Your doctor's instructions should be strictly followed, especially if you encounter any side effects from Altanib NOVA 400 mg Tablet. These side effects, such as dizziness, fatigue, and difficulty concentrating and coordinating, have the potential to hinder your capability to drive a vehicle safely. Taking necessary precautions, such as refraining from driving or operating heavy machinery, is essential to ensure your well-being while using Altanib NOVA Tablet.